Post on 17-Jan-2020
Acyanotic Congenital Heart Disease:Left-to-Right Shunt Lesions
Jamie N. Colombo, DO,* Michael A. McCulloch, MD*
*Department of Pediatrics, Division of Pediatric Cardiology, University of Virginia Children’s Hospital, Charlottesville, VA
Education Gap
An understanding of the pathophysiology, diagnosis, and appropriate initial
management of acyanotic congenital heart disease is needed to
appropriately care for infants in the NICU.
Abstract
Acyanotic congenital heart diseases or left-to-right shunting lesions are the
most common form of congenital heart disease. Although most resolve
spontaneously, many will remain hemodynamically significant, particularly in
the premature infant. Understanding the difference in pathophysiology,
diagnosis, and management between the term and preterm infant is
imperative to minimize the risk of secondary organ dysfunction and ensure
proper growth and development.
Objectives After completing this article, readers should be able to:
1. Explain the pathophysiology, initial presentation, andmanagement of left-
to-right pre-tricuspid shunt lesions.
2. Explain the pathophysiology, initial presentation, andmanagement of left-
to-right post-tricuspid shunt lesions.
3. List the genetic mutations associated with the different left-to-right shunt
lesions.
4. Differentiate the effects of these lesions on term and preterm infants.
INTRODUCTION
Congenital heart disease (CHD) is the most common genetic abnormality, with
an incidence that increases from approximately 8 per 1,000 term births to 12.5
per 1,000 premature births. (1)(2)More important, however, are the significantly in-
creased hemodynamic consequences of CHD in preterm infants compared with
their term peers. This review will focus on acyanotic CHD defined as an anatomic
connection between the pulmonary and systemic circulations in which oxygenated
AUTHOR DISCLOSURE Drs Colombo andMcCulloch have disclosed no financialrelationships relevant to this article. Thiscommentary does not contain a discussionof an unapproved/investigative use of acommercial product/device.
ABBREVIATIONS
ASD atrial septal defect
AVSD atrioventricular septal defect
CHD congenital heart disease
ECG electrocardiography
PDA patent ductus arteriosus
PVR pulmonary vascular resistance
Qp pulmonary blood flow
Qs systemic blood flow
SVR systemic vascular resistance
VSD ventricular septal defect
Vol. 19 No. 7 JULY 2018 e375 by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
systemic blood flow on the left side of the heart shunts to the
partially deoxygenated pulmonary bloodflowon the right side
of the heart. The vast array of acyanotic heart lesions will
be grouped into 2 physiologic subtypes of pre-tricuspid valve
and post-tricuspid valve shunting. Further consideration will
be given to gestational age when appropriate.
PRE-TRICUSPID VALVE SHUNTS
The physiologic distinction of pre-tricuspid valve shunts de-
scribes shunting across an atrial septal defect (ASD) during
ventricular diastole and atrial systole. The direction of flow
across an atrial communication is dictated by differences in
ventricular compliance. Ventricular compliance can change
when chronic atrial contraction occurs into a ventricle that
has become stiff and noncompliant either from myopathic
changes (ie, hypertrophic cardiomyopathy) or from chroni-
cally elevated afterload (ie, pulmonary/aortic valve stenosis
or elevated pulmonary or systemic vascular resistance).
Shortly after birth, ASD shunt magnitude is low because
neonatal right ventricular stiffness and compliance are very
similar to those in the left ventricle. With physiologic de-
clines in pulmonary vascular resistance, compensatory in
utero right ventricular hypertrophy regresses, resulting in a
more compliant right ventricle and atrium. This allows a
progressive left-to-right increase in ASD shunt volume that
is further pronounced with larger defect size. (3) ASDs are
considered volume-loading defects to the right heart (as
opposed to pressure-loading defects; see Post-Tricuspid
Valve Shunts section), with larger defects producing right
atrial and ventricular dilation.
IncidenceExcluding patent foramen ovale, which persists in up to 35%
of adults, ASDs exist in approximately 1 in 1,500 children,
comprise 6% to 10% of all cardiac anomalies, (4) and are
the most commonly recognized mutation in nonsyndromic
CHD. (5) Although ASDs frequently occur with other con-
genital heart lesions, isolated ASDs have been associated with
NKX2.5,GATA4,GATA6, andTBX20mutations.Mutations in
the TXB5 gene are associated with Holt-Oram syndrome.
Several anatomic classifications of atrial defects can occur
in uterowhen the septumprimumand septum secundumdo
not appropriately fuse with each other, the endocardial cush-
ions, and posterior aspect of the atria. Ostium secundum type
defects compose 75% of all ASDs and are essentially identical
to a patent foramen ovale with the major distinction being
size. (4) The foramenovale is a critical connectionmaintained
throughout fetal life, directing oxygenated ductus venosus
blood across its opening to the left atrium, left ventricle,
preductal aortic vessels, and the developing brain. Primum
ASDs exist in the setting of atrioventricular septal defects
(AVSDs) but their physiologic presentation is typically deter-
mined more by the associated lesions. Sinus venosus type
ASDs comprise 4% to 11% of all ASD types and are com-
monly associated with anomalous return of at least 1 pulmo-
nary vein, resulting in a significantly larger left-to-right
shunt. (6) Coronary sinus ASDs not only produce ASD phys-
iology but are commonly associated with systemic desatu-
ration as they functionally “unroof” the coronary sinus,
adding markedly desaturated blood into the left atrium.
DiagnosisASDs are rarely associated with clinical findings in the term
neonate. At 2 to 3 years of age, classic findings include a
widely split S2 and a systolic ejection murmur along the left
sternal border because of increased flow across the pulmo-
nary valve. Echocardiography is the diagnostic tool of choice
(Fig 1). Chest radiography may show an enlarged cardiac
silhouette and increased pulmonary vascular markings, but
this can be difficult to appreciate in an infant with lung
disease. Electrocardiography (ECG) will show right ventric-
ular hypertrophy and right axis deviation, but this is true in
all newborns and is usually not helpful.
ManagementTerm neonates with isolated ASDs are typically asymptom-
atic and rarely require intervention. Should the patient
develop significant signs of congestion with increased work
of breathing, tachypnea, hepatomegaly, and poor growth,
diuretics are the first-line treatment. As such, ASD closure
is not common until at least 2 years of age, with both de-
vice closure in the catheterization laboratory and surgical
closure having excellent results. (7)(8)
Premature InfantsThe premature infant with chronic lung disease represents
a unique challenge. When subjected to chronic hyperoxia
and positive pressure ventilation, the immature lung paren-
chyma exhibits alveolar simplification. (9) The subsequent
reduced number of alveoli renders these infants particularly
sensitive to any increase in pulmonary blood flow, par-
ticularly when coupled with aspiration, inflammation, or
acquired pulmonary vein stenosis, all of which result in
congestion from increased intra-alveolar fluid. Therefore,
premature infants not following the expected perinatal
course (ie, respiratory distress out of proportion to their
lung disease) who have an ASD deemed amenable to device
closure in the cardiac catheterization laboratory should be
considered for this therapy to improve outcomes. (10)(11)
e376 NeoReviews by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
POST-TRICUSPID VALVE SHUNTS
Left-to-right shunting lesions distal to the tricuspid valve
include various ventricular septal defects (VSDs; eg, peri-
membranous VSD and atrioventricular canal defects) and
systemic to pulmonary shunts (eg, patent ductus arteriosus
[PDA] and aortopulmonary window). The hemodynamic
significance of a shunt depends on the size and resistance
within the defect, and the relationship between pulmonary
vascular resistance (PVR) and systemic vascular resistance
(SVR). Inutero and immediately after birth, thePVRand SVR
are approximately equal, producing a PVR/SVR ratio of 1:1.
After a healthy newborn takes the first breath, the pulmonary
vascular bed is exposed to oxygen, promoting pulmonary
arteriolar relaxation and a progressive decrease in the PVR/
SVR ratio. PVR reaches its nadir between 8 weeks and 6
months of age, resulting in a PVR/SVR ratio of 0.2:1 or less.
Regardless of the size and resistance within a post-tricuspid
valve communication, net shunting of blood will not occur
until the PVR/SVR ratio has deviated significantly from 1:1
(ie, an increase in pulmonary blood flow relative to systemic
blood flow cannot occur until PVR is less than SVR).
The PVR/SVR ratio effectively acts as the second in a
series of 2 resistors, with the first being the communication
itself. The Hagen-Poiseuille equation states that resistance
to flow across a vessel is directly related to its length and
inversely related to its radius to the fourth power (R¼ L/ r4).
VSDs have no length and act as a static resistor in the
neonate, therefore, the resistance to flow across the VSD is
entirely determined by the radius or size of the defect. By
comparison, a PDA has significant length and its radius is
affected by both contraction of oxygen-sensitive ductal tissue
and angulations within a tortuous ductus. However, the
relative resistance that exists within the pulmonary and
systemic vascular beds is markedly greater than that found
within the defects themselves, and is subsequently the
largest determinant of shunting volume and direction.
These complex interactions ultimately determine whether
a post-tricuspid valve shunting lesion produces a pressure
and/or volume burden on the heart and lungs.
VSD shunting occurs exclusively during systole. Large
nonrestrictive VSDs are associated with pulmonary arterial
pressures identical to systemic arterial pressures, regardless
of the PVR/SVR ratio. This is because pressure generation
within a vascular bed is the product of its vascular resistance
(PVR and SVR) and pulmonary (Qp) and systemic (Qs)
blood flow ejected into that bed. For example, if the ratio of
resistance is 1:1, there is no net shunting (Qp:Qs ¼ 1:1), but
if the PVR/SVR ratio is 0.5:1 and the Qp:Qs is 2:1, the
pulmonary circulation is exposed to twice as much blood
flow as is the systemic circulation.
VSDs in the setting of a low PVR/SVR ratio (ie, <0.5:1)
produce a volume burden on both the lungs and left
ventricle. Excess pulmonary blood flow shunted from the
left ventricle combines with the right ventricular output and
produces hydrostatic pressures that overwhelm oncotic
forces, resulting in intra-alveolar water or pulmonary
edema. This total blood volume must then return to the
left atrium and ventricle, progressively dilating both cham-
bers. Newborns with such ventricular level shunting
become increasingly tachypneic, intolerant of oral feedings,
and fail to thrive, producing the classic presentation of
congestive heart failure. This rate of decline is reduced with
smaller defects and if the PVR/SVR is closer to 1:1. Large,
Figure 1. Subcostal echocardiogram of a secundum atrial septal defect (indicated by arrow) with and without color. LA¼left atrium; LV¼left ventricle;RA¼right atrium; RV¼right ventricle.
Vol. 19 No. 7 JULY 2018 e377 by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
long-standing, unrepaired VSDs cause progressive pul-
monary arteriolar vasoconstriction and PVR elevation that
eventually becomes irreversible, resulting in Eisenmenger syn-
drome; this is exceedingly rare in the first few years of age.
Although the length of a PDA directly increases resis-
tance, compared with a large VSD, PDAs typically produce a
larger volume burden on the pulmonary vascular bed for 2
reasons. First, a newborn’s ductus arteriosus is large, with a
cross-sectional area equal to the descending aorta, largely
counteracting the resistance effect of its length. Second,
shunting occurs throughout both systole and diastole.
VENTRICULAR SEPTAL DEFECT
IncidenceVSDs are themost common form of CHD, representing 20%
to 30% of isolated lesions and occurring in 1.3 to 3.9 of 1,000
live births. (12)(13) VSDs are classified as 4 types, with perimem-
branous VSDs being the most common. (14) Isolated VSDs are
the most common CHD seen in patients with trisomy 21, 18,
and 13, but only 5% to 8% of patients with an isolated VSD
will have a chromosomal disorder. (13)TBX5,GATA4, andNKX2
mutations have been associated with isolated VSDs. (13)
DiagnosisSmall, restrictive VSDs are often found incidentally with a
holosystolic murmur at the left sternal border, but only after
PVR has begun to fall. Because of the lack of flow acceler-
ation and associated murmur, large defects may not become
clinically evident until an infant becomes symptomatic, as
described earlier. Chest radiography may show signs of
pulmonary congestion and an enlarged cardiac silhouette.
An ECG may show signs of left and right ventricle hyper-
trophy with disease progression, but are typically not diag-
nostic. Echocardiography is the diagnostic tool of choice
(Fig 2) and additional testing is not usually indicated.
ManagementUp to 45% of VSDs spontaneously close during the first year
of age. (12) For those that become hemodynamically signif-
icant, surgical closure is the primary option, depending on
the location of the defect and size of the child, with low
morbidity and mortality rates and excellent outcomes. (12)
Premature infants with VSDs are particularly challenging
because their incomplete pulmonary arteriolar development
produces an extremely compliant pulmonary vascular bed,
resulting in an earlier onset of pulmonary overcirculation
and congestive heart failure. This is further complicated
in patients with chronic lung disease. Pulmonary artery
banding may be considered if there are multiple defects
within the ventricular septum or if the infant’s size or
gestational age precludes cardiopulmonary bypass. (12)
ATRIOVENTRICULAR SEPTAL DEFECT
IncidenceAVSDs comprise a wide variety of congenital heart lesions
involving endocardial cushion formation. The spectrum
ranges from partial defects with a primum ASD and mitral
valve cleft (most common type) to a complete defect with an
ASD, VSD, and single atrioventricular valve to an unbalanced
AVSD with heterotaxy syndrome and single ventricle physiol-
ogy. (15)(16) The incidence of AVSDs ranges from 0.24 to 0.31
per 1,000 live births or 4% to 5% of congenital heart defects
and 40% of cases will be associated with trisomy 21. (16)(17)
AVSD is associated with tetralogy of Fallot in 5% of cases. (16)
DiagnosisA complete AVSD is commonly diagnosed prenatally. (16)
(17) Defects with large ventricular components will present
earlier in life when PVR falls, as discussed earlier. Diagnosis
is made with echocardiography (Fig 3), but ECG can be a
helpful screening test because it commonly shows the
unique finding of a superior QRS axis between –90 and
–120 degrees (Fig 4).
ManagementDefinitive management is surgical, with current mortality
rates less than 3%when performed between 3 and 6months
of age, which increases in younger, smaller infants. (18) The
concurrent diagnosis of trisomy 21 syndrome does not
significantly alter morbidity or mortality rates unless surgi-
cal intervention is made significantly later than 6 months
of age, because of an inherently earlier development of
irreversible pulmonary vascular disease. (16)
PATENT DUCTUS ARTERIOSUS
IncidenceThe PDA is a vital structure in utero, redirecting blood from
the right ventricle to the lower body. After a term gestation,
the PDA will usually close within 72 hours of age, but fre-
quently this does not occur untilmuch later in preterm infants,
making it the most common lesion of prematurity. (19)(20)
DiagnosisPatients may demonstrate a widened pulse pressure with
bounding distal pulses; auscultation of the left upper sternal
border will demonstrate either a continuous murmur
e378 NeoReviews by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
produced by shunting throughout the cardiac cycle or an
isolated systolic murmur either when the PVR remains
high or as the ductus begins to close and diastolic flow
ceases. As with other left-to-right shunts, echocardiography
is the diagnostic tool of choice. Some investigators have
demonstrated serum brain natriuretic peptide to be another
indicator of PDAs in premature infants. (19)(21)
ManagementSpontaneous PDA closure is more likely to occur in infants
without respiratory distress syndrome, those born after 28
weeks’ gestation (w73%), and those born with birthweights
greater than 1,000 g (w 94%). (19)(22) When closure does
not occur, it is reasonable to consider intervening in the
setting of chronic renal insufficiency, feeding intolerance,
hemodynamic instability, or inability to separate from sup-
plemental respiratory support.Nonsteroidal anti-inflammatory
agents such as indomethacin and ibuprofen are commonly
considered first-line therapy. However, their mechanism of
action (cyclooxygenase inhibition with downstream inhibi-
tion of prostaglandin formation) (23)(24) also carries a sig-
nificant risk of acute renal injury, intracranial hemorrhage,
and spontaneous intestinal perforation. This challenge has
prompted investigation into alternative medical interven-
tions such as intravenous acetaminophen. (24)
Surgical ligation is another option, but is associated with
risks of vocal cordor diaphragmparesis, scoliosis, or accidental
ligation of the pulmonary artery or aorta. (25) Percutaneous
device occlusion is yet another option, but higher rates of
arterial injury and device embolization are reported in infants
who weigh less than 4 kg. (25) Considering the complicated
risk-benefit profile associated with these options, the decision
Figure 3. Apical echocardiogram of an atrioventricular septal defectshowing a primum atrial septal defect (top arrow), a commonatrioventricular valve, and an inlet ventricular septal defect (bottomarrow). LA¼left atrium; LV¼left ventricle; RA¼right atrium; RV¼rightventricle.
Figure 2. Echocardiogram in parasternal long axis view, with and without color, demonstrating a perimembranous ventricular septal defect (indicatedby arrow). LA¼left atrium; RV¼right ventricle; LV¼left ventricle.
Vol. 19 No. 7 JULY 2018 e379 by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
to intervene in an infant with a PDA should not follow a
protocol, but instead be individualized for each patient.
Premature InfantsSome data suggest that the premature ductus arteriosus is
less sensitive to the vasoconstrictive properties of oxygen
and more sensitive to the vasodilatory effects of endogenous
prostaglandin E2, (26) resulting in the higher prevalence
of ductal patency in this population. As with VSDs in the
premature infant, PDAs can be especially challenging be-
cause they contribute to heart failure, bronchopulmonary
dysplasia, necrotizing enterocolitis, renal insufficiency, cere-
bral palsy, and prolonged need for ventilator support. (19)
AORTOPULMONARY WINDOW
Aortopulmonary windows are a rare (0.2%–0.6% of CHD)
systemic to pulmonary communication associated with
severe pulmonary overcirculation, heart failure, and respi-
ratory failure. (27) This defect occurs during embryonic
septation of the truncus arteriosus in which the 2 vessels
have a region devoid of intervening tissue. Without any
interposing resistor such as a semilunar valve or length of
ductus arteriosus, there is no functional separation between
the systemic and pulmonary vascular beds and patients
become symptomatic at very young ages. Physical exami-
nation findings are typically indistinguishable from those of
a large PDA. Echocardiographic diagnosis can be challeng-
ing but should be suspected in patients with a clinical
picture of heart failure without a PDA or VSD. Surgical
patch septation is the definitive intervention.
CONCLUSION
Left-to-right shunting lesions should be physiologically and
anatomically subcategorized into pre- and post-tricuspid
valve. Pre-tricuspid valve lesions include ASDs in which
shunting is determined by defect size and differences in
ventricular compliance. These lesions produce right heart
enlargement and are usually asymptomatic throughout
infancy. Post-tricuspid valve lesions include VSDs, AVSDs,
PDAs, and aortopulmonary windows, in which shunting is
determined largely by the relationship between the systemic
and pulmonary vascular resistances but also by the resistance
inherent in the interposing defect. Initially, these lesions
produce a volume burden on the lungs and left ventricle,
and can lead to progressive respiratory failure, heart failure,
and failure to thrive. Untreated, any of these lesions can
progressively result in Eisenmenger syndrome, which is
associated with a significantly worse prognosis. Premature
infants and those with chronic lung disease are particularly
sensitive to left-to-right shunting lesions and should be
considered for early medical or surgical intervention.
References1. Sadowski SL. Congenital cardiac disease in the newborn infant:past, present, and future. Crit Care Nurs Clin North Am. 2009;21(1):37–48, vi
2. Hoffman JIE, Kaplan S. The incidence of congenital heart disease.J Am Coll Cardiol. 2002;39(12):1890–1900
3. Mahoney LT. Acyanotic congenital heart disease: atrial andventricular septal defects, atrioventricular canal, patent ductusarteriosus, pulmonic stenosis. Cardiol Clin. 1993;11(4):603–616
4. Ooi YK, Kelleman M, Ehrlich A, et al. Transcatheter versus surgicalclosure of atrial septal defects in children a value comparison. JACCCardiovasc Interv. 2016;9(1):79–86
5. Posch MG, Perrot A, Berger F, Ozcelik C. Molecular genetics ofcongenital atrial septal defects. Clin Res Cardiol. 2010;99(3):137–147
Figure 4. Electrocardiogram of a patient with an atrioventricular septaldefect demonstrating a superior QRS axis (predominantly negative QRSwaveform in lead I and aVF) consistent with an endocardial cushiondefect.
American Board of PediatricsNeonatal-Perinatal ContentSpecifications• Know the anatomy and pathophysiology (including genetics) ofa neonate with a left-to-right shunt lesion.
• Recognize the clinical features of a neonate with a left-to-rightshunt lesion.
• Recognize the laboratory, imaging, and other diagnostic featuresof a neonate with a left-to-right shunt lesion.
• Formulate a differential diagnosis for a neonate with a left-to-right shunt lesion.
• Know the evaluation and medical and/or surgical managementand associated potential complications or adverse effects ofsuch management for a neonate with a left-to-right shuntlesion.
e380 NeoReviews by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
6. Attenhofer Jost CH, Connolly HM, Danielson GK, et al. Sinusvenosus atrial septal defect: long-term postoperative outcome for 115patients. Circulation. 2005;112(13):1953–1958
7. Butera G, De Rosa G, Chessa M, et al. Transcatheter closure of atrialseptal defect in young children: results and follow-up. J Am CollCardiol. 2003;42(2):241–245
8. Moore J, Hegde S, El-Said H, et al; ACC IMPACT SteeringCommittee. Transcatheter device closure of atrial septal defects: asafety review. JACC Cardiovasc Interv. 2013;6(5):433–442
9. Kumar VHS. Diagnostic approach to pulmonary hypertension inpremature neonates. Children (Basel). 2017;4(9):75
10. Wood AM, Holzer RJ, Texter KM, et al. Transcatheter elimination ofleft-to-right shunts in infants with bronchopulmonary dysplasia isfeasible and safe. Congenit Heart Dis. 2011;6(4):330–337
11. Lim DS, Matherne GP. Percutaneous device closure of atrial septaldefect in a premature infant with rapid improvement in pulmonarystatus. Pediatrics. 2007;119(2):398–400
12. Penny DJ, Vick GW III. Ventricular septal defect. Lancet. 2011;377(9771):1103–1112
13. Minette MS, Sahn DJ. Ventricular septal defects. Circulation.2006;114(20):2190–2197
14. Soto B, Becker AE,Moulaert AJ, Lie JT, Anderson RH. Classificationof ventricular septal defects. Br Heart J. 1980;43(3):332–343
15. Hills CB, Kochilas L, Schimmenti LA, Moller JH. Ellis-van Creveldsyndrome and congenital heart defects: presentation of anadditional 32 cases. Pediatr Cardiol. 2011;32(7):977–982
16. Craig B. Atrioventricular septal defect: from fetus to adult. Heart.2006;92(12):1879–1885
17. Morlando M, Bhide A, Familiari A, et al. The association betweenprenatal atrioventricular septal defects and chromosomalabnormalities. Eur J Obstet Gynecol Reprod Biol. 2017;208:31–35
18. St Louis JD, Jodhka U, Jacobs JP, et al. Contemporary outcomes ofcomplete atrioventricular septal defect repair: analysis of the Societyof Thoracic Surgeons Congenital Heart Surgery Database. J ThoracCardiovasc Surg. 2014;148(6):2526–2531
19. Benitz WE; Committee on Fetus and Newborn, American Academyof Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics.2016;137(1):e20153730
20. Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenitalheart disease. Am Heart J. 2004;147(3):425–439
21. Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M,Pammi M. Diagnosing significant PDA using natriuretic peptidesin preterm neonates: a systematic review. Pediatrics. 2015;135(2):e510–e525
22. Avsar MK, Demir T, Celiksular C, Zeybek C. Bedside PDA ligationin premature infants less than 28 weeks and 1000 grams.J Cardiothorac Surg. 2016;11(1):146
23. Bardanzellu F, Neroni P, Dessì A, Fanos V. Paracetamol in patentductus arteriosus treatment: efficacious and safe? Biomed Res Int.2017;2017:1–25
24. Oncel MY, Erdeve O. Oral medications regarding their safety andefficacy in themanagement of patent ductus arteriosus.World J Clin
Pediatr. 2016;5(1):75–81
25. Backes CH, Kennedy KF, Locke M, et al. Transcatheter occlusion ofthe patent ductus arteriosus in 747 infants<6 kg: Insights from theNCDR IMPACT Registry. JACC Cardiovasc Interv. 2017;10(17):1729–1737
26. Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J PediatrPharmacol Ther. 2007;12(3):138–146
27. Kutsche LM, Van Mierop LHS. Anatomy and pathogenesisof aorticopulmonary septal defect. Am J Cardiol. 1987;59(5):443–447
Vol. 19 No. 7 JULY 2018 e381 by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
NeoReviews QuizThere are two ways to access the journal CME quizzes:
1. Individual CME quizzes are available via a handy blue CME link in the Table of Contents of any issue.
2. To access all CME articles, click “Journal CME” from Gateway’s orange main menu or go directly to: http://www.
aappublications.org/content/journal-cme.
NOTE: Learners can takeNeoReviews quizzes andclaim credit online onlyat: http://Neoreviews.org.
To successfully complete2018 NeoReviews articlesfor AMA PRA Category 1CreditTM, learners mustdemonstrate a minimumperformance level of 60%or higher on thisassessment, whichmeasures achievement ofthe educational purposeand/or objectives of thisactivity. If you score lessthan 60% on theassessment, you will begiven additionalopportunities to answerquestions until an overall60% or greater score isachieved.
This journal-based CMEactivity is availablethrough Dec. 31, 2020,however, credit will berecorded in the year inwhich the learnercompletes the quiz.
2018 NeoReviews now isapproved for a total of 10Maintenance ofCertification (MOC) Part 2credits by the AmericanBoard of Pediatricsthrough the ABP MOCPortfolio Program.Complete the first 5 issuesor a total of 10 quizzes ofjournal CME credits,achieve a 60% passingscore on each, and startclaiming MOC credits asearly as May 2018.
1. A newborn with a murmur undergoes echocardiography and is noted to have an atrialseptal defect (ASD). It is reported that ASDs occur in approximately 1 in 1,500 children andaccount for 6% to 10% of all cardiac anomalies. Which of the following subtypesconstitutes the most common type of ASD?
A. Ostium primum ASD.B. Sinus venosus type ASD.C. Ostium secundum ASD.D. Coronary sinus ASD.E. Mixed ASD.
2. In utero and immediately after birth, the ratio of pulmonary vascular resistance (PVR) tosystemic vascular resistance (SVR) is approximately 1:1. With exposure of the pulmonaryvascular bed to oxygen, the PVR/SVR ratio progressively decreases. When does the PVRnadir occur in a healthy neonate?
A. At 1 week of age.B. Between 2 and 4 weeks of age.C. Between 4 and 8 weeks of age.D. Between 8 weeks and 6 months of age.E. Between 6 months and 12 months of age.
3. A male term newborn is noted at 1 day of age to have a holosystolic murmur.Echocardiography reveals a ventricular septal defect (VSD). VSDs are the most commonform of congenital heart disease, representing 20% to 30% of isolated lesions and occur-ring in 1.3 to 3.9 of 1,000 live births. Which of the following statements is FALSE regardingthe physiology of VSDs?
A. VSDs in the setting of a low PVR/SVR ratio (ie,<0.5:1) produce a pressure burden onboth the lungs and left ventricle.
B. Pulmonary edema is the result of excess pulmonary blood flow with resultantincreased hydrostatic pressures.
C. The classic presentation of a large hemodynamically significant VSD includestachypnea, intolerance of oral feeds, and failure to thrive.
D. If untreated, excess pulmonary blood flow can lead to progressive pulmonaryarteriolar vasoconstriction and irreversible PVR elevation (Eisenmenger syndrome).
E. Due to the lack of flow acceleration and associated murmur, large defects may notbecome clinically evident until an infant becomes symptomatic.
4. A female term newborn has features of trisomy 21 and part of the evaluation includesechocardiography, which reveals an atrioventricular septal defect (AVSD). AVSDs accountfor 4% to 5% of congenital heart defects and 40% of cases are associated with trisomy 21.Which of the following electrocardiographic (ECG) findings is unique to AVSDs?
A. Presence of right ventricular hypertrophy and right axis deviation.B. Presence of a superior QRS axis between –90 and –120 degrees.C. Presence of peaked, large amplitude p waves in lead II.D. Presence of left ventricular hypertrophy with left axis deviation.E. Presence of prolonged PR interval.
5. An infant born at 34 weeks’ gestational age has respiratory distress and is placed oncontinuous positive airway pressure. Chest radiography shows a large cardiac shadow andcardiac murmur. The patient continues to have respiratory distress and oxygenrequirement at 2 days of age and echocardiography is performed. Patent ductus arteriosus(PDA) is present, but otherwise the cardiac anatomy is normal. In full-term infants, the PDAusually closes within 72 hours of age. Which of the following statements is also correctregarding PDAs?
e382 NeoReviews by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
A. As with ventricular septal defects, shunting occurs exclusively in systole.B. The premature ductus arteriosus is less sensitive to the vasodilatory effects of
endogenous prostaglandin E2.C. The PDA ismore likely to spontaneously close in infants without respiratory distress
syndrome.D. The PDA spontaneously closes in approximately 75% of preterm infants with a
birthweight above 1,000 g.E. The rate of complications associated with percutaneous device occlusion of the
PDA is similar in older children and neonates weighing more than 2,500 g.
Vol. 19 No. 7 JULY 2018 e383 by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
DOI: 10.1542/neo.19-7-e3752018;19;e375NeoReviews
Jamie N. Colombo and Michael A. McCullochAcyanotic Congenital Heart Disease: Left-to-Right Shunt Lesions
ServicesUpdated Information &
http://neoreviews.aappublications.org/content/19/7/e375including high resolution figures, can be found at:
Referenceshttp://neoreviews.aappublications.org/content/19/7/e375#BIBLThis article cites 27 articles, 12 of which you can access for free at:
Subspecialty Collections
_drug_labeling_updatehttp://classic.neoreviews.aappublications.org/cgi/collection/pediatricPediatric Drug Labeling Updatefollowing collection(s): This article, along with others on similar topics, appears in the
Permissions & Licensing
htmlhttp://classic.neoreviews.aappublications.org/site/misc/Permissions.xin its entirety can be found online at: Information about reproducing this article in parts (figures, tables) or
Reprintshttp://classic.neoreviews.aappublications.org/site/misc/reprints.xhtmlInformation about ordering reprints can be found online:
by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from
DOI: 10.1542/neo.19-7-e3752018;19;e375NeoReviews
Jamie N. Colombo and Michael A. McCullochAcyanotic Congenital Heart Disease: Left-to-Right Shunt Lesions
http://neoreviews.aappublications.org/content/19/7/e375located on the World Wide Web at:
The online version of this article, along with updated information and services, is
ISSN: 1526-9906. 60007. Copyright © 2018 by the American Academy of Pediatrics. All rights reserved. Online the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois,it has been published continuously since . Neoreviews is owned, published, and trademarked by Neoreviews is the official journal of the American Academy of Pediatrics. A monthly publication,
by guest on July 25, 2018http://neoreviews.aappublications.org/Downloaded from